India, once the ‘pharmacy of the world’, is struggling to establish itself as an elite player due to poor manufacturing practices that have led to deaths in some parts of the world, including children. The deaths of children in the West African nation of Gambia in 2022 and the deaths of 65 children in Uzbekistan last year have highlighted the lapse in the quality of drug production in certain India-based pharmaceuticals.